Cortex Vision

Cortex Vision develops AI-based clinical tools, including ABIGAIL (noninvasive classification of high-grade gliomas from MRI and clinical data), BRAIN (automatic detection of intracranial bleeding on CT scans), BRIDGE and CLEAN (clinical data harmonization and automated clinical document generation), and GhostEMR, a GDPR-oriented de-identification software for electronic health records. Per the website, ABIGAIL, BRAIN, BRIDGE and CLEAN are at TRL 2–3, while GhostEMR is at TRL 9.

The website names healthcare institutions as the target audience, enabling them to share and analyze patient data for research and quality improvement. The website does not describe pricing or a revenue model. The team is drawn from academic researchers and clinicians, and the company is affiliated with UVP TECHNICOM, an innovation hub in Košice.

The company was founded in 2022 and is based in Košice, Slovakia, where its partners include Louis Pasteur University Hospital, Pavol Jozef Šafárik University and the Technical University of Košice. The website lists contacts for Peter Drotar, Jakub Gazda and Matej Gazda, but no hiring information.

Product: Medical AI software: ABIGAIL and BRAIN diagnostic AI in development, BRIDGE/CLEAN data and documentation tools, and GhostEMR EHR de-identification software.